By Professor Susan Jane Connor

Book Chapters

Connor S; Wu Y, 2024, 'WHAT ARE THE RISKS OF BIOLOGIC THERAPIES AND HOW DO YOU COMMUNICATE THEM TO PATIENTS?', in Curbside Consultation in Ibd 49 Clinical Questions, pp. 115 - 121, http://dx.doi.org/10.1201/9781003523567-23

Journal articles

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Brosbol Ravnborg A; Mwaura-Ruhio TN; Rous L, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Clinical Gastroenterology and Hepatology, 23, pp. S1 - S60, http://dx.doi.org/10.1016/j.cgh.2025.04.005

Sun J; Brooks EC; Houshyar Y; Connor SJ; Paven G; Grimm MC; Hold GL, 2025, 'Unravelling the Relationship between Obesity and Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2547 - 2560, http://dx.doi.org/10.1093/ibd/izaf098

Pipicella JL; Dutt S; Thacker K; Connor SJ; Andrews JM; Vernon-Roberts A, 2025, 'Crohn's Colitis Care, a Disease-Specific Electronic Medical Record, Enhances Data Capture in Pediatric Inflammatory Bowel Disease Care', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70153

Whiley PJ; Dixit OVA; Das Gupta M; Patel H; Zhao G; Connor SJ; Summers KM; Hume DA; Pavli P; O'Brien CL, 2025, 'Transcriptomic signatures of host immune responses in aphthous ulcers, the earliest lesions of Crohn's disease, suggest that bacterial uptake, rather than global dysbiosis, is the initiating factor', Immunology and Cell Biology, 103, pp. 473 - 484, http://dx.doi.org/10.1111/imcb.70031

Pipicella JL; Gu B; McNamara J; Wilson W; Palmer LJ; Connor SJ; Andrews JM, 2025, 'Proposal and exploration of a novel score to quantify patient-perceived burden of inflammatory bowel disease under routine care', Internal Medicine Journal, 55, pp. 589 - 598, http://dx.doi.org/10.1111/imj.16634

Abeyratne K; Harb M; Bensted K; Ghaly S; Connor SJ; Andrews JM; Lynch KD, 2025, 'Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas', Internal Medicine Journal, 55, pp. 461 - 466, http://dx.doi.org/10.1111/imj.16648

Little R; Jayawardana T; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'Association of gut microbiota changes and disease activity in patients with Crohn's disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2425 - i2426, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519

Su WK; Mcnamara J; Wilson W; Wark G; Lynch K; Su H; Forbes A; Lawrance I; An YK; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn's Colitis Cure Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i111 - i112, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0054

Pudipeddi A; Lin H; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', JOURNAL OF CROHNS & COLITIS, 19, pp. I1453 - I1454, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0928

Davidson C; Su WK; Wilson W; Rivas C; Antoniades S; Wark G; Su H; Ghaly S; Grafton R; Andrews JM; Connor SJ, 2025, 'Factors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation: Crohn's Colitis Cure Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i2481 - i2482, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1558

Koentgen S; Cosier D; Tavakoli P; Leach ST; Dutt S; Ghaly S; Connor SJ; Lemberg DA; Lambert K; Hold GL, 2025, 'Fat rich dietary habits: Further increasing IBD risk in first degree relatives', JOURNAL OF CROHNS & COLITIS, 19, pp. i356 - i356, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192

Su WK; Wilson W; Ng W; Su H; Forbes A; Walker G; Kim A; Giles E; Lawrance I; Dutt S; Brett L; An YK; Lynch K; Connor SJ; Andrews JM, 2025, 'Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn's Colitis Cure Data Insights Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i277 - i278, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0145

Little R; Jayawardana T; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2413 - i2415, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Australia IBDMAIMS, 2025, 'Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2422 - i2424, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Tavakoli P; Sidhu S; Le A; Boussioutas A; Ward MG; Miles S; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Australia IBDMAIMS, 2025, 'Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2391 - i2392, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501

Alsulaibi O; Su WK; Wilson W; Sin L; Ng W; Walker G; Forbes A; Lawrance I; Lynch K; Begun J; Connor SJ; Andrews JM, 2025, 'Mortality and comorbidities in people with Inflammatory Bowel Disease - Crohn's Colitis Cure data insights program', JOURNAL OF CROHNS & COLITIS, 19, pp. i1141 - i1142, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0742

Cabaero AG; Su WK; Wilson W; Rivas C; Antoniades S; Ng W; Forbes A; Arnold K; Grafton R; Andrews JM; Connor SJ, 2025, 'N36 Inflammatory bowel disease helpline use amongst individuals who are culturally and linguistically diverse, Crohn’s Colitis Cure Data Insight’s Programme', Journal of Crohn's and Colitis, 19, pp. i2495 - i2496, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1568

Pudipeddi A; Dhanji P; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i689 - i690, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0431

Chan P; Su WK; Wilson W; Cabaero A; Antoniades S; Forbes A; Arnold K; Grafton R; Andrews J; Connor S, 2025, 'P0569 Inflammatory Bowel Disease nursing helpline trends in a large real-world Australasian cohort: Crohn's Colitis Cure (CCC) data insights program', Journal of Crohn's and Colitis, 19, pp. i1142 - i1143, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0743

Su WK; Wilson W; Wark G; Ghaly S; Lynch K; Lawrance I; Walker G; Forbes A; Brett L; An YK; Connor SJ; Andrews JM, 2025, 'P0603 The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i1197 - i1198, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0777

Pinnuck B; Su WK; Wilson W; Pipicella J; Ng W; Antoniades S; Walker G; Forbes A; Dutt S; Lynch K; Connor SJ; Andrews JM, 2025, 'P0678 Iron deficiency, with or without anaemia, in Inflammatory Bowel Disease remains an undermanaged issue: Crohn’s Colitis Cure Data Insights Program', Journal of Crohn's and Colitis, 19, pp. i1327 - i1328, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0852

Pinnuck B; Su WK; Wilson W; Pipicella J; Wark G; Archdiacono M; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Lynch K; Connor SJ; Andrews JM, 2025, 'P0938 Corticosteroid and opiate use in Inflammatory Bowel Disease, 25 years after the Crohn's Therapy, Resource, Evaluation, and Assessment Tool (TREAT) registry was established', JOURNAL OF CROHNS & COLITIS, 19, pp. i1760 - i1760, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1112

Barnett M; Su WK; Pipicella J; Kaur H; Wilson W; Connor SJ; Andrews JM, 2025, 'P0950 Comparing Real-World use of Dietary and Medical Therapies in Children and Adults with IBD', Journal of Crohn's and Colitis, 19, pp. i1775 - i1775, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1124

Cameron K; Sam M; Theena N; Gu B; Arzivian A; Skinner T; Shelton E; Connor SJ; Toong C; Gibson PR; Gibson DJ; Sparrow MP; Ward MG, 2025, 'P0967 The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy (RAPID-IM Study)', JOURNAL OF CROHNS & COLITIS, 19, pp. i1799 - i1799, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1141

Seng C; Su WK; Wilson W; Connor SJ; Andrews JM; Walker G, 2025, 'P1225 A cross-sectional study of Inflammatory Bowel Disease in older people across Australasia, a Crohn’s Colitis Cure data insights program', Journal of Crohn's and Colitis, 19, pp. i2216 - i2217, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1399

Gu B; Su WK; Nano D; Wilson W; Iliescu S; Lynch K; Andrews JM; Connor SJ; Ghaly S, 2025, 'P1281 Active perianal fistulising Crohn’s Disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use', Journal of Crohn's and Colitis, 19, pp. i2311 - i2312, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1455

Rivas C; Su WK; Wilson W; Ng W; Ghaly S; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor S, 2025, 'Patterns and predictors of steroid use in people with IBD in routine care across ANZ', JOURNAL OF CROHNS & COLITIS, 19, pp. i2077 - i2077, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1306

De Gregorio M; Winata LS; Behrenbruch CC; Hartley I; Connor SJ; D'Souza B; Johnston MJ; Kamm MA; Keck JO; Rimola J; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2025, 'Scoring indices grading radiologic disease activity severity on magnetic resonance imaging strongly reflect clinical healing of Crohn's perianal fistulas', JOURNAL OF CROHNS & COLITIS, 19, pp. I693 - I693, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0434

Cosier D; Lambert K; Karen C; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg D; Houshyar Y; Jayawardana T; Koentgen S; Hold G, 2025, 'The interplay between dietary intake and disease activity in Australian adults with and without Inflammatory Bowel Disease', JOURNAL OF CROHNS & COLITIS, 19, pp. I1468 - I1468, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0933

Koentgen S; Zhang F; Wu N; Jayawardana T; Little R; Tavakoli P; Ghaly S; Connor SJ; Hold GL, 2025, 'Unique faecal & oral microbiota signatures in first degree relatives of inflammatory bowel disease patients', JOURNAL OF CROHNS & COLITIS, 19, pp. i606 - i606, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0377

Su WK; Wilson W; Wark G; Walker G; Su H; Forbes A; Kim A; Giles E; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor SJ, 2025, 'Variation in healthcare utilisation amongst IBD care centres in Australia and New Zealand, Crohn's Colitis Care Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. I808 - I809, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0515

Van Oostrom J; Anjie S; Lasa J; Karimi N; Horrigan J; Sareen H; Adi B; Ganesh G; Parks ML; Broer C; de Kruif A; Peyrin-Biroulet L; Ye BD; Banerjee R; Olivera P; Siegel C; Connor S; Gecse K; D'Haens G; IBD LC, 2025, 'World-wide Development and Validation of the IBD LIFE Questionnaire and Country-specific Patterns of Normal Life Impairment', JOURNAL OF CROHNS & COLITIS, 19, pp. i965 - i966, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0624

De Gregorio M; Winata LS; Hartley I; Behrenbruch CC; Connor SJ; D‘Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJS; Schulberg JD; Srinivasan A; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2025, 'A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn’s perianal fistulas', Journal of Crohn S and Colitis, 19, http://dx.doi.org/10.1093/ecco-jcc/jjae199

Cohen NA; Sror N; Naseer M; Bettenworth D; Lu C; Khedraki R; Abreu MT; Atreya R; Al-Bawardy B; Connor SJ; d'Haens G; Dotan I; Dignass A; El Ouali S; Feagan B; Feakins R; Gearry R; Gordon IO; Hedin C; Kobayashi T; Leibovitzh H; Maharshak N; Ollech J; Sebastian S; Siegmund B; Rubin DT; Silverberg MS; Steinwurz F; Torres J; Watermeyer G; Hernandez-Rocha C; Gurizzian P; Silfen A; Tzadok R; Falloon K; Rieder F, 2025, 'Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review', Clinical Gastroenterology and Hepatology, http://dx.doi.org/10.1016/j.cgh.2025.03.024

McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2025, 'Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort', Gastro Hep Advances, 4, http://dx.doi.org/10.1016/j.gastha.2024.100594

Anandabaskaran S; Hanna L; Becker M; Buskens C; McDonald BD; Rubin DT; Carvello M; Spinelli A; Geldof J; De Looze D; Chan P; Connor SJ; Lundby L; Dige A; Bislenghi G; Vermeire S; Hart A; Tozer P, 2025, 'Functional validation of the TOpClass classification system for perianal fistulising Crohn’s disease using real-world multicentre data: a 10-year retrospective observational study', Frontline Gastroenterology, http://dx.doi.org/10.1136/flgastro-2025-103198

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Ravnborg AB; Mwaura-Ruhio TN; Rous L, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Alimentary Pharmacology and Therapeutics, http://dx.doi.org/10.1111/apt.70290

Karimi N; Moore AR; Jones A; Lukin A; Pipicella JL; Williams AJ; Ng W; Kanazaki R; Kariyawasam V; Mitrev N; Pandya K; Andrews JM; Connor SJ, 2025, 'On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease', Patient Education and Counseling, 130, http://dx.doi.org/10.1016/j.pec.2024.108487

Akyüz F; An YK; Begun J; Aniwan S; Bui HH; Chan W; Choi CH; Chopdat N; Connor SJ; Desai D; Flanagan E; Kobayashi T; Lai AYH; Leong RW; Leow AHR; Leung WK; Limsrivilai J; Muzellina VN; Peddi K; Ran Z; Wei SC; Sollano J; Teo MMH; Wu K; Ye BD; Ooi CJ, 2025, 'Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition', Intestinal Research, 23, pp. 37 - 55, http://dx.doi.org/10.5217/ir.2024.00089

Hanna LN; Munster LJ; Joshi S; Wendelien van der Bilt JD; Buskens CJ; Hart A; Tozer P; TOpClass Collaborators , 2025, 'Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice.', Lancet Gastroenterol Hepatol, 10, pp. 757 - 768, http://dx.doi.org/10.1016/S2468-1253(25)00007-X

Pinnuck BC; Su WK; Wilson WE; Pipicella JL; Ng W; Antoniades SA; Walker G; Forbes AJ; Dutt S; Lynch KD; Connor SJ; Andrews J, 2025, 'Mo1891: IRON DEFICIENCY, WITH OR WITHOUT ANAEMIA, IN INFLAMMATORY BOWEL DISEASE REMAINS AN UNDERMANAGED ISSUE: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)03678-9

Su WK; McNamara J; Wilson WE; Wark G; Lynch KD; Su HY; Forbes AJ; Lawrance IC; An Y-K; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Mo1954: CONSISTENCY AND QUALITY OF INFLAMMATORY BOWEL DISEASE CARE IN AUSTRALASIA; TOWARDS BENCHMARKING.', Gastroenterology, 169, pp. S - 1240, http://dx.doi.org/10.1016/s0016-5085(25)03741-2

Jayawardana TC; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong RW; Connor SJ; Hold GL, 2025, 'Mo1960: IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY.', Gastroenterology, 169, pp. S - 1243, http://dx.doi.org/10.1016/s0016-5085(25)03747-3

Oostrom J; Anjie SI; Lasa JS; Karimi N; Horrigan J; Sareen H; Adi B; Ganesh G; Yang S-K; Parks L; Broër C; de Kruif A; Peyrin-Biroulet L; Ye BD; Banerjee R; Sendra PO; Siegel CA; Connor SJ; Gecse K; D’Haens G, 2025, 'Mo1964: THE IBD LIFE QUESTIONNAIRE: WORLD-WIDE DEVELOPMENT AND VALIDATION AND INTERCONTINENTAL DIFFERENCES OF NORMAL LIFE IMPAIRMENT', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)03751-5

Little RD; Jayawardana TC; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL, 2025, 'Sa1795: GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, pp. S - 532, http://dx.doi.org/10.1016/s0016-5085(25)02163-8

Pinnuck BC; Su WK; Wilson WE; Pipicella JL; Wark G; arcidiacono M; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Lynch KD; Connor SJ; Andrews J, 2025, 'Sa1917: CORTICOSTERIOD AND OPIATE USE IN INFLAMMATORY BOWEL DISEASE, 25 YEARS AFTER THE CROHN’S THERAPY, RESOURCE, EVALUATION, AND ASSESSMENT TOOL (TREAT) WAS ESTABLISHED', Gastroenterology, 169, pp. S - 583, http://dx.doi.org/10.1016/s0016-5085(25)02279-6

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1899: EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 879, http://dx.doi.org/10.1016/s0016-5085(25)02960-9

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 900, http://dx.doi.org/10.1016/s0016-5085(25)03004-5

Rivas C; Su WK; Wilson WE; Ng W; Ghaly S; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Begun J; Lynch KD; Andrews JM; Connor SJ, 2025, 'Tu1094: PATTERNS AND PREDICTORS OF STEROID USE IN PEOPLE WITH IBD IN ROUTINE CARE ACROSS ANZ', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)03886-7

Back to profile page